The donor of carbon monoxide (CORM-2) affects the level of serum immunoglobulins and the state of the bone marrow during the immune response in mice
DOI:
https://doi.org/10.14739/2409-2932.2020.3.216229Keywords:
gas transmitter, carbon monoxide, CORM-2, humoral immune responseAbstract
Toxic carbon monoxide in small concentrations has pro-apoptotic, anti-allergic, vasodilator effects, and stimulates angiogenesis. The problem with the therapeutic use of low doses of carbon monoxide is that it is difficult to dose. To control the amount and gradual release of carbon monoxide, non-toxic preparation is used - CO donor based on carbonyl compound of ruthenium (CORM-2).
The aim – is to identify the effect of CORM-2 on the level of immunoglobulins in the blood serum and bone marrow of mice under conditions of inducing an immune response.
Materials and methods. 3 groups of 15 white laboratory mice each were formed. Induction of the immune response was due to the intraperitoneal administration of xenogenic red blood cells. The first experimental group on the first day of immunization received CORM-2 (20 mg/kg), group No. 2 – on the 5th day after immunization (period of the productive phase). The control group consisted of immunized animals that did not receive CORM-2. The amount of IgA, IgM, and IgG in blood serum was determined by ELISA on the 2nd and 6th day after immunization. At the end of the experiment, bone marrow cell populations were counted.
Results. After the injection of CORM-2 during the induction phase of the immune response, it inhibits the production of immunoglobulins. In comparison with the control, the level of IgA and IgG is reduced, but the amount of IgM remains unchanged. In the bone marrow, the number of monocytes, erythroblasts, and normoblasts, as well as lymphoblasts and plasma cells, increased. At the same time, the number of myeloblasts, myelocytes, basophilic normoblasts, and megakaryocytes decreased. The use of CORM-2 during the productive phase caused a decrease in the level of IgM and IgG with a simultaneous increase in the level of IgA. The number of neutrophils, eosinophils, monocytes, polychromophilic and oxyphilic normoblasts, lymphocytes, and plasma cells in the bone marrow increased. However, the number of myeloblasts, promyelocytes, myelocytes, metamyelocytes, basophilic normoblasts, and megakaryocytes decreased.
Conclusions. The impact of the CORM-2 on the inductive phase of the immune response leads to inhibition of the production of immunoglobulins. The injection of CORM-2 during the productive phase of the immune response decreased the level of IgM and IgG, but at the same time, an increase in the level of IgA was observed. After the injection of CORM-2, in the bone marrow, the number of monocytes, lymphocytes, and plasma cells increased. The results indicate that CORM-2 is able to modulate the immune response.
References
Gladka, I. V., & Shkuropat, A. V. (2016). Efektyvnist khimichnykh ta biolohichnykh metodiv preventsii rozvytku bakterioziv plodiv Capsicum anuum [Effectiveness of chemical and biological methods of prevention of bacteriosis Capsicum anuum]. Pryrodnychyi almanakh. Seria: Biolohichni nauky, (23), 13-19. [in Ukrainian]. http://na.kspu.edu/index.php/na/article/view/462
Fayad-Kobeissi, S., Ratovonantenaina, J., Dabiré, H., Wilson, J. L., Rodriguez, A. M., Berdeaux, A., Dubois-Randé, J., Mann, B., Motterlini, R., & Foresti, R. (2016). Vascular and angiogenic activities of CORM-401, an oxidant-sensitive CO-releasing molecule. Biochemical Pharmacology, 102, 64-77. https://doi.org/10.1016/j.bcp.2015.12.014
Ji, X., Damera, K., Zheng, Y., Yu, B., Otterbein, L. E., & Wang, B. (2016). Toward Carbon Monoxide-Based Therapeutics: Critical Drug Delivery and Developability Issues. Journal of pharmaceutical sciences, 105(2), 406-416. https://doi.org/10.1016/j.xphs.2015.10.018
Kolupaev, Yu. E., Karpets, Yu. V., Beschasniy, S. P., & Dmitriev, A. P. (2019). Gasotransmitters and their role in adaptive reactions of plant cells. Cytology and Genetics. 53, 392-406. https://doi.org/10.3103/S0095452719050098
Rose, J. J., Wang, L., Xu, Q., McTiernan, C. F., Shiva, S., Tejero, J., & Gladwin, M. T. (2017). Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy. American journal of respiratory and critical care medicine, 195(5), 596-606. https://doi.org/10.1164/rccm.201606-1275CI
Olas, B. (2014). Carbon monoxide is not always a poison gas for human organism: Physiological and pharmacological features of CO. Chemico-biological interactions, 222, 37-43. https://doi.org/10.1016/j.cbi.2014.08.005
Beschasnyi, S., & Hasiuk, O. (2020). CO-Releasing Molecule (CORM-2) in the Regulation of Ca2+-Dependent K+-Permeability of Erythrocyte. Ukrainian Journal of Medicine, Biology and Sport, 5(2), 166-171. https://doi.org/10.26693/jmbs05.02.166
Park, J., Joe, Y., Ryter, S. W., Surh, Y. J., & Chung, H. T. (2019). Similarities and Distinctions in the Effects of Metformin and Carbon Monoxide in Immunometabolism. Molecules and cells, 42(4), 292-300. https://doi.org/10.14348/molcells.2019.0016
Motterlini, R., & Foresti, R. (2017). Biological signaling by carbon monoxide and carbon monoxide-releasing molecules. American journal of physiology. Cell physiology, 312(3), C302-C313. https://doi.org/10.1152/ajpcell.00360.2016
Ryter, S. W., & Choi, A. M. (2016). Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Translational research : the journal of laboratory and clinical medicine, 167(1), 7-34. https://doi.org/10.1016/j.trsl.2015.06.011
Adach, W., & Olas, B. (2017). The role of CORM-2 as a modulator of oxidative stress and hemostatic parameters of human plasma in vitro. PloS one, 12(9), e0184787. https://doi.org/10.1371/journal.pone.0184787
Magierowski, M., Magierowska, K., Hubalewska-Mazgaj, M., Sliwowski, Z., Ginter, G., Pajdo, R., Chmura, A., Kwiecien, S., & Brzozowski, T. (2017). Carbon monoxide released from its pharmacological donor, tricarbonyldichlororuthenium (II) dimer, accelerates the healing of pre-existing gastric ulcers. British journal of pharmacology, 174(20), 3654-3668. https://doi.org/10.1111/bph.13968
Tashireva, L. A., Starikova, E. G., Novickij, V. V., & Rjazanceva, N. V. (2012). Vnutrikletochnye misheni proapoptoticheskogo vlijanija gazovyh transmitterov [Intracellular targets of proapoptotic influence of gaseous transmitters]. Annals of the Russian academy of medical sciences, 67(10), 77-81. [in Russian]. https://doi.org/10.15690/vramn.v67i10.420
Starikova, Ye. G. (2012). Antiproliferativnyi potentsial monooksida ugleroda [Antiproliferative potential of carbon monoxide]. Bulletin of Siberian Medicine, 11(4), 68-71. [in Russian]. https://doi.org/10.20538/1682-0363-2012-4-68-71
Mahan V. L. (2020). Cardiac function dependence on carbon monoxide. Medical gas research, 10(1), 37-46. https://doi.org/10.4103/2045-9912.279982
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
